Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
262.93
+0.93 (0.36%)
Nov 22, 2024, 4:00 PM EST - Market closed

Company Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

The company’s Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours.

The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.

Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation
Insulet logo
Country United States
Founded 2000
IPO Date May 15, 2007
Industry Medical Devices
Sector Healthcare
Employees 3,000
CEO James Hollingshead

Contact Details

Address:
100 Nagog Park
Acton, Massachusetts 01720
United States
Phone 978 600 7000
Website insulet.com

Stock Details

Ticker Symbol PODD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001145197
CUSIP Number 45784P101
ISIN Number US45784P1012
Employer ID 04-3523891
SIC Code 3841

Key Executives

Name Position
Dr. James R. Hollingshead Ph.D. President, Chief Executive Officer and Director
Lauren Budden Group Vice President, Chief Accounting Officer and Controller
Mark Field Senior Vice President and Chief Technology Officer
Eric Benjamin Executive Vice President, Chief Product and Customer Experience Officer
Ana Maria Chadwick Executive Vice President, Chief Financial Officer and Treasurer
Prem Singh Senior Vice President of Global Operations
Deborah R. Gordon CPA Vice President of Investor Relations
Laetitia Cousin Senior Vice President of Regulatory Affairs, Quality Assurance and Compliance
Angela Geryak Wiczek Senior Director of Corporate Communications
Philip Hildale Senior Vice President of Sales and Customer Care

Latest SEC Filings

Date Type Title
Nov 12, 2024 144 Filing
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 10-Q Quarterly Report
Nov 7, 2024 8-K Current Report
Oct 7, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 11, 2024 144 Filing
Sep 10, 2024 144 Filing
Sep 9, 2024 144 Filing
Sep 9, 2024 144 Filing
Aug 30, 2024 144 Filing